COM:CORVUSPHARMA
Corvus Pharmaceuticals
- Stock
Last Close
2.31
26/07 20:00
Market Cap
118.85M
Beta: -
Volume Today
405.00K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 361K - | -207.50K 157.48% | -994.50K 379.28% | -727K 26.90% | -708.50K 2.54% | -653.50K 7.76% | -579.50K 11.32% | -701K 20.97% | -367.50K 47.57% | ||
average payables | 816K - | 1.74M 112.93% | 2.68M 54.07% | 2.73M 1.83% | 2.22M 18.45% | 2.96M 33.04% | 2.52M 14.93% | 1.77M 29.63% | 1.75M 1.13% | ||
average receivables | 173.50K - | 356K 105.19% | 248.50K 30.20% | 234.50K 5.63% | 333K 42.00% | 207.50K 37.69% | 312.50K 50.60% | 586K 87.52% | 329.50K 43.77% | ||
book value per share | -1.52 - | 8.61 665.00% | 4.14 51.92% | 4.01 3.14% | 2.42 39.59% | 2.45 1.01% | 2.32 5.15% | 1.21 48.08% | 0.00 99.93% | ||
capex per share | -0.09 - | -0.14 66.55% | -0.01 90.89% | -0.01 0.60% | -0.00 93.40% | -0.00 202.67% | -0.00 95.37% | -0.01 4,736.91% | -0.00 99.99% | ||
capex to depreciation | -11.80 - | -3.70 68.64% | -0.32 91.47% | -0.42 32.67% | -0.03 91.97% | -0.12 257.39% | -0.01 90.96% | -0.73 6,643.32% | -0.23 69.28% | ||
capex to operating cash flow | 0.15 - | 0.08 48.81% | 0.01 92.71% | 0.01 50.47% | 0.00 92.27% | 0.00 226.23% | 0.00 93.77% | 0.01 7,209.58% | 0.00 85.73% | ||
capex to revenue | |||||||||||
cash per share | 4.63 - | 17.17 271.14% | 6.59 61.62% | 6.91 4.81% | 2.66 61.53% | 1.50 43.49% | 1.66 10.52% | 0.91 45.24% | 0.00 99.94% | ||
days of inventory on hand | |||||||||||
days payables outstanding | |||||||||||
days sales outstanding | |||||||||||
debt to assets | 0.21 - | 0.07 - | 0.04 36.99% | 0.06 37.84% | 0.06 2.02% | 0.03 48.21% | |||||
debt to equity | -16.35 - | 0.08 - | 0.05 36.50% | 0.06 30.98% | 0.07 10.13% | 0.04 49.85% | |||||
dividend yield | |||||||||||
earnings yield | -0.11 - | -0.16 53.06% | -0.26 58.99% | -0.46 77.29% | -0.27 41.07% | -0.05 83.23% | -0.38 724.05% | -1.26 233.98% | -0.00 99.97% | ||
enterprise value | -9.92M - | 286.69M 2,990.85% | 85.64M 70.13% | 122.21M 42.70% | -13.64M 111.16% | 157.70M 1,256.52% | 90.80M 42.42% | 41.06M 54.78% | 29.01M 29.34% | 84.51B 291,199.55% | |
enterprise value over ebitda | -21.05 - | -2.32 89.00% | -2.16 6.65% | 0.28 112.81% | -3.23 1,265.23% | -2.07 35.72% | -0.95 54.22% | -0.89 6.27% | -3.61K 405,444.43% | ||
ev to operating cash flow | -25.31 - | -3.07 87.85% | -2.64 13.98% | 0.33 112.58% | -4.23 1,370.16% | -2.61 38.21% | -1.12 57.17% | -1.07 3.99% | -3.53K 328,781.88% | ||
ev to sales | |||||||||||
free cash flow per share | -0.64 - | -1.95 204.17% | -2.27 16.40% | -1.50 33.75% | -1.27 15.33% | -1.18 7.08% | -0.88 25.80% | -0.59 33.18% | -0.00 99.91% | ||
free cash flow yield | -0.04 - | -0.14 203.10% | -0.22 60.67% | -0.41 87.01% | -0.23 42.88% | -0.33 41.99% | -0.36 9.61% | -0.69 89.46% | -0.00 99.96% | ||
graham net net | -1.69 - | 16.67 1,084.56% | 6.09 63.48% | 6.62 8.70% | 2.22 66.39% | 1.04 53.19% | 1.37 31.31% | 0.65 52.42% | 0.00 99.94% | ||
graham number | 7.26 - | 21.38 194.59% | 15.91 25.58% | 12.41 22.00% | 9.01 27.36% | 3.00 66.70% | 6.90 130.03% | 5.40 21.79% | 0.00 99.94% | ||
income quality | 0.36 - | 0.77 111.84% | 0.83 8.41% | 0.87 5.18% | 0.80 8.43% | 5.80 625.47% | 0.85 85.36% | 0.65 22.95% | 0.89 35.36% | ||
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -61.52 - | -21.56 - | -22.39 3.85% | -81.04 261.94% | -2.58K 3,077.97% | -49.79 98.07% | -14.78 70.32% | ||||
interest debt per share | 0.04 - | 0.08 - | 0.26 215.31% | 0.14 47.08% | 0.15 8.06% | 0.10 33.57% | 0.00 99.94% | ||||
inventory turnover | |||||||||||
invested capital | -16.35 - | 0.08 - | 0.05 36.50% | 0.06 30.98% | 0.07 10.13% | 0.04 49.85% | |||||
market cap | 290.79M - | 220.54M 24.16% | 212.26M 3.75% | 100.96M 52.44% | 159.66M 58.14% | 104.94M 34.27% | 100.87M 3.88% | 39.57M 60.77% | 84.52B 213,504.87% | ||
net current asset value | -159K - | -33.90M 21,218.87% | 127.55M 476.28% | 80.11M 37.19% | 106.70M 33.18% | 65.45M 38.66% | 30.88M 52.82% | 57.16M 85.11% | 30.18M 47.20% | 21.09M 30.12% | |
net debt to ebitda | 0.30 - | 3.65 1,110.62% | 1.59 56.33% | 2.33 46.13% | 0.04 98.27% | 0.32 703.23% | 1.38 328.07% | 0.32 76.58% | 0.48 48.29% | ||
net income per share | -1.54 - | -2.36 53.60% | -2.72 15.18% | -1.71 37.20% | -1.49 12.64% | -0.16 89.02% | -0.91 457.85% | -1.08 17.79% | -0.00 99.95% | ||
operating cash flow per share | -0.56 - | -1.81 225.39% | -2.26 24.87% | -1.49 33.94% | -1.27 14.65% | -1.18 7.22% | -0.88 25.64% | -0.58 33.83% | -0.00 99.91% | ||
payables turnover | |||||||||||
receivables turnover | |||||||||||
research and ddevelopement to revenue | |||||||||||
return on tangible assets | -0.32 - | -0.26 18.45% | -0.59 126.29% | -0.40 32.40% | -0.52 31.74% | -0.06 89.22% | -0.35 518.90% | -0.73 110.15% | -0.59 19.10% | ||
revenue per share | |||||||||||
roe | 1.01 - | -0.27 127.19% | -0.66 139.55% | -0.43 35.16% | -0.62 44.61% | -0.07 89.13% | -0.39 488.13% | -0.89 126.86% | -0.70 21.66% | ||
roic | 0.44 - | -0.27 161.93% | -0.66 139.59% | -0.47 28.71% | -0.57 22.67% | -0.45 21.35% | -0.32 29.37% | -0.63 97.45% | -0.56 10.24% | ||
sales general and administrative to revenue | |||||||||||
shareholders equity per share | -1.52 - | 8.61 665.00% | 4.14 51.92% | 4.01 3.14% | 2.42 39.59% | 2.45 1.01% | 2.32 5.15% | 1.21 48.08% | 0.00 99.93% | ||
stock based compensation to revenue | |||||||||||
tangible asset value | -159K - | -31.10M 19,460.38% | 132.80M 527.00% | 84.83M 36.12% | 110.34M 30.06% | 71.11M 35.55% | 72.15M 1.46% | 97.16M 34.67% | 56.12M 42.25% | 38.68M 31.06% | |
tangible book value per share | -1.52 - | 8.61 665.00% | 4.14 51.92% | 4.01 3.14% | 2.42 39.59% | 2.45 1.01% | 2.32 5.15% | 1.21 48.08% | 0.00 99.93% | ||
working capital | 9.86M - | 92.59M 839.55% | 127.55M 37.75% | 80.11M 37.19% | 106.70M 33.18% | 65.45M 38.66% | 30.88M 52.82% | 57.16M 85.11% | 30.18M 47.20% | 21.09M 30.12% |
All numbers in (except ratios and percentages)